Advertisement
Screener

CRONOS GROUP INC. (CRON) Increase (Decrease) in Accounts Payable and Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Increase (Decrease) in Accounts Payable and Other Operating Liabilities

CRONOS GROUP INC. (CRON) reported Increase (Decrease) in Accounts Payable and Other Operating Liabilities of -$11.09 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-02-18.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities · last filed 2022-02-18

  • CRONOS GROUP INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2021-09-30 was $2.32M, a 76.17% decline year-over-year.
  • CRONOS GROUP INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2021-06-30 was -$737.00K.
  • CRONOS GROUP INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2021-03-31 was -$12.68M, a 721.63% decline year-over-year.
  • CRONOS GROUP INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2020-12-31 was $2.84M.
  • CRONOS GROUP INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2020 was $4.17M, a 69.02% decline from fiscal 2019.
  • CRONOS GROUP INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2019 was $13.48M, a 6.07% increase from fiscal 2018.
  • CRONOS GROUP INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2018 was $12.71M, a 146.03% increase from fiscal 2017.
  • CRONOS GROUP INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2017 was $5.16M.
Period endIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 3 month as first filedIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 6 month as first filedIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 9 month as first filedIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 12 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 12 month as first filed
2021-09-30$2.32M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18
$1.59M
derived: sum of 2 quarters · filed 2022-02-18
-$11.09M
10-Q · filed 2022-02-18
-$8.25M
derived: sum of 4 quarters · filed 2022-02-18
2021-06-30-$737.00K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18
-$13.41M
10-Q/A · filed 2022-02-18
-$10.57M
derived: sum of 3 quarters · filed 2022-02-18
-$820.00K
derived: sum of 4 quarters · filed 2022-02-18
2021-03-31-$12.68M
10-Q · filed 2021-05-07
-$9.83M
derived: sum of 2 quarters · filed 2021-05-07
-$83.00K
derived: sum of 3 quarters · filed 2022-02-18
-$10.54M
derived: sum of 4 quarters · filed 2022-02-18
2020-12-31$2.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$12.59M
derived: sum of 2 quarters · filed 2022-02-18
$2.14M
derived: sum of 3 quarters · filed 2022-02-18
$4.17M
10-K · filed 2021-02-26
2020-09-30$9.75M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18
-$706.00K
derived: sum of 2 quarters · filed 2022-02-18
$1.33M
10-Q · filed 2022-02-18
$3.71M
10-Q · filed 2020-11-05
-$8.87M
derived: sum of 4 quarters · filed 2022-02-18
2020-06-30-$10.46M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18
-$8.42M
10-Q/A · filed 2022-02-18
-$6.99M
10-Q · filed 2020-08-06
-$18.62M
derived: sum of 3 quarters · filed 2022-02-18
-$4.82M
derived: sum of 4 quarters · filed 2022-02-18
2020-03-31$2.04M
10-Q · filed 2021-05-07
-$1.01M
10-Q · filed 2020-05-08
-$8.16M
derived: sum of 2 quarters · filed 2021-05-07
$5.64M
derived: sum of 3 quarters · filed 2021-05-07
-$5.33M
derived: sum of 4 quarters · filed 2021-05-07
2019-12-31-$10.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$3.60M
derived: sum of 2 quarters · filed 2021-02-26
-$7.37M
derived: sum of 3 quarters · filed 2021-02-26
$13.48M
10-K · filed 2021-02-26
$13.32M
10-K/A · filed 2020-03-30
2019-09-30$13.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$2.83M
derived: sum of 2 quarters · filed 2020-11-05
$23.68M
10-Q · filed 2020-11-05
2019-06-30-$10.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$9.88M
10-Q · filed 2020-08-06
2019-03-31$20.84M
10-Q · filed 2020-05-08
2018-12-31$12.71M
10-K · filed 2021-02-26
2017-12-31$5.16M
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87